Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chengkun Yang

Showing results (51-60 of 73) with videos related to

Pageof 8
Sort By:
International Journal of Oncology|August 22, 2019
Genome‑wide investigation of the clinical implications and molecular mechanism of long noncoding RNA LINC00668 and protein‑coding genes in hepatocellular carcinomaXiangkun Wang, Xin Zhou, Junqi Liu, et al.
Translational Cancer Research|February 4, 2022
Establishment of a prognostic model for predicting short-term disease-free survival in cases of hepatitis B-related hepatocellular carcinoma with the TP53 249Ser mutation in southern ChinaWei Qin, Chuangye Han, Rongyun Mai, et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|August 10, 2018
Identification of Potential Prognostic Long Non-Coding RNA Biomarkers for Predicting Survival in Patients with Hepatocellular CarcinomaXiwen Liao, Chengkun Yang, Rui Huang, et al.
Journal of Cancer|January 2, 2024
Sarcosine dehydrogenase as an immune infiltration-associated biomarker for the prognosis of hepatocellular carcinomaHaixiang Xie, Kejian Yang, Chongjiu Qin, et al.
International Journal of Oncology|September 6, 2019
Analysis of clinical significance and prospective molecular mechanism of main elements of the JAK/STAT pathway in hepatocellular carcinomaXiangkun Wang, Xiwen Liao, Tingdong Yu, et al.
Journal of Cancer|July 21, 2018
Distinct Diagnostic and Prognostic Values of Minichromosome Maintenance Gene Expression in Patients with Hepatocellular CarcinomaXiwen Liao, Xiaoguang Liu, Chengkun Yang, et al.
Cancer Medicine|December 7, 2019
Noteworthy prognostic value of phospholipase C delta genes in early stage pancreatic ductal adenocarcinoma patients after pancreaticoduodenectomy and potential molecular mechanismsXin Zhou, Xiwen Liao, Xiangkun Wang, et al.
International Journal of Surgery (London, England)|July 7, 2022
A novel Peng's test in reducing bile leakage after partial hepatectomy for hepatocellular carcinoma: From an animal study to a clinical cohort Propensity score matching comparative studyShutian Mo, Yongfei He, Guangzhi Zhu, et al.
Oncology Reports|August 22, 2019
Clinical significance and prospective molecular mechanism of C‑C motif chemokine receptors in patients with early‑stage pancreatic ductal adenocarcinoma after pancreaticoduodenectomyXin Zhou, Xiwen Liao, Xiangkun Wang, et al.
Oncology Reports|May 23, 2019
Investigation of the clinical significance and prospective molecular mechanisms of cystatin genes in patients with hepatitis B virus‑related hepatocellular carcinomaXin Zhou, Xiangkun Wang, Ketuan Huang, et al.
Pageof 8

Showing results (51-60 of 73) with videos related to

Sort By:
Pageof 8
International Journal of Oncology|August 22, 2019
Genome‑wide investigation of the clinical implications and molecular mechanism of long noncoding RNA LINC00668 and protein‑coding genes in hepatocellular carcinomaXiangkun Wang, Xin Zhou, Junqi Liu, et al.
Translational Cancer Research|February 4, 2022
Establishment of a prognostic model for predicting short-term disease-free survival in cases of hepatitis B-related hepatocellular carcinoma with the TP53 249Ser mutation in southern ChinaWei Qin, Chuangye Han, Rongyun Mai, et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|August 10, 2018
Identification of Potential Prognostic Long Non-Coding RNA Biomarkers for Predicting Survival in Patients with Hepatocellular CarcinomaXiwen Liao, Chengkun Yang, Rui Huang, et al.
Journal of Cancer|January 2, 2024
Sarcosine dehydrogenase as an immune infiltration-associated biomarker for the prognosis of hepatocellular carcinomaHaixiang Xie, Kejian Yang, Chongjiu Qin, et al.
International Journal of Oncology|September 6, 2019
Analysis of clinical significance and prospective molecular mechanism of main elements of the JAK/STAT pathway in hepatocellular carcinomaXiangkun Wang, Xiwen Liao, Tingdong Yu, et al.
Journal of Cancer|July 21, 2018
Distinct Diagnostic and Prognostic Values of Minichromosome Maintenance Gene Expression in Patients with Hepatocellular CarcinomaXiwen Liao, Xiaoguang Liu, Chengkun Yang, et al.
Cancer Medicine|December 7, 2019
Noteworthy prognostic value of phospholipase C delta genes in early stage pancreatic ductal adenocarcinoma patients after pancreaticoduodenectomy and potential molecular mechanismsXin Zhou, Xiwen Liao, Xiangkun Wang, et al.
International Journal of Surgery (London, England)|July 7, 2022
A novel Peng's test in reducing bile leakage after partial hepatectomy for hepatocellular carcinoma: From an animal study to a clinical cohort Propensity score matching comparative studyShutian Mo, Yongfei He, Guangzhi Zhu, et al.
Oncology Reports|August 22, 2019
Clinical significance and prospective molecular mechanism of C‑C motif chemokine receptors in patients with early‑stage pancreatic ductal adenocarcinoma after pancreaticoduodenectomyXin Zhou, Xiwen Liao, Xiangkun Wang, et al.
Oncology Reports|May 23, 2019
Investigation of the clinical significance and prospective molecular mechanisms of cystatin genes in patients with hepatitis B virus‑related hepatocellular carcinomaXin Zhou, Xiangkun Wang, Ketuan Huang, et al.
Pageof 8